For in vitro suppression studies, 1×104 FACS sorted (>98% purity) CD4+ YFP− conventional T cells from LNs and spleens of Foxp3YFP-Cre/Cre mice were labeled with 5 μM CellTrace Violet and stimulated with 250 ng/ml of αCD3 mAb (145–2c11, Biolegend) in presence of 2.5 × 104 T-cell depleted splenocytes and different concentrations (from 1:1 to 1:16) of Miltenyi (negative selection) enriched CD4+ and FACS sorted (>98% purity) YFPbright Treg cells from LNs and spleens of Foxp3YFP-Cre/+ x CARMA1f/f (or f/+ or +/+) x Rosa26STOP f/f-YFP mice. CD4+ YFP− conventional T cell proliferation was read out after 72h, as previously described.41 (link) Briefly, percentage of suppression was scaled from 0 (proliferation of conventional T cell in absence of Treg) to 100 (complete absence of proliferation).
In vivo and in vitro Treg suppression assays
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Massachusetts General Hospital
Other organizations : Boston Children's Hospital, Center for Cancer Research, University of Padua
Variable analysis
- Presence or absence of 1×10^5 Miltenyi (negative selection) enriched CD4+ and FCAS sorted (>98% purity) YFPbright Treg cells from LNs and spleens of Foxp3YFP-Cre/+ x CARMA1f/f (or f/+ or +/+) x Rosa26STOP f/f-YFP mice
- Concentrations of Miltenyi (negative selection) enriched CD4+ and FACS sorted (>98% purity) YFPbright Treg cells from LNs and spleens of Foxp3YFP-Cre/+ x CARMA1f/f (or f/+ or +/+) x Rosa26STOP f/f-YFP mice (from 1:1 to 1:16 ratio with conventional T cells)
- In vivo suppression of 3×10^5 Miltenyi (negative selection) enriched CD4+ and FACS sorted (>98% purity) CD45RBhigh YFP− cells from LNs and spleens of Foxp3YFP-Cre/Cre mice
- In vitro proliferation of 1×10^4 FACS sorted (>98% purity) CD4+ YFP− conventional T cells from LNs and spleens of Foxp3YFP-Cre/Cre mice, as measured by CellTrace Violet dye dilution after 72h of stimulation with 250 ng/ml of αCD3 mAb
- 3×10^5 Miltenyi (negative selection) enriched CD4+ and FACS sorted (>98% purity) CD45RBhigh YFP− cells from LNs and spleens of Foxp3YFP-Cre/Cre mice
- 2.5 × 10^4 T-cell depleted splenocytes used for in vitro stimulation
- Presence of 1×10^5 Miltenyi (negative selection) enriched CD4+ and FCAS sorted (>98% purity) YFPbright Treg cells from LNs and spleens of Foxp3YFP-Cre/+ x CARMA1f/f (or f/+ or +/+) x Rosa26STOP f/f-YFP mice
- Absence of 1×10^5 Miltenyi (negative selection) enriched CD4+ and FCAS sorted (>98% purity) YFPbright Treg cells from LNs and spleens of Foxp3YFP-Cre/+ x CARMA1f/f (or f/+ or +/+) x Rosa26STOP f/f-YFP mice
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!